ctDNA Testing Shows Promise for Influencing Colorectal Cancer Treatment

(MedPage Today) -- SAN FRANCISCO -- Circulating tumor DNA (ctDNA) measurements showed promise for identifying patients with early colorectal cancer (CRC) most likely to benefit from adjuvant therapy, analyses of two large clinical trials suggested...